Humacyte First Quarter 2024 Financial Results and Business Update
May 10, 2024 07:00 ET
|
Humacyte, Inc
-Biologics License Application (BLA) for HAV™ Accepted by FDA- -BLA Granted Priority Review for Vascular Trauma Indication; PDUFA date set for August 10, 2024- -Raised approximately $43...
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
May 09, 2024 07:00 ET
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund...
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
May 08, 2024 06:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
May 06, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
May 02, 2024 09:00 ET
|
GlucoTrack, Inc.
Continuous blood glucose monitor’s preclinical data and sensor longevity modeling to be presented at major diabetes conference Rutherford, NJ, May 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc....
Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B
May 02, 2024 08:00 ET
|
Intuity Medical
FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic®...
Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers
April 30, 2024 09:00 ET
|
Discovery Therapeutics Caribe, LLC
FDA approves Discovery Therapeutic Caribe's Phase 3 trial for intralesional rhEGF in severe diabetic foot ulcers.
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
April 30, 2024 08:38 ET
|
Fractyl Health, Inc.
Fractyl Health Announces Multiple Presentations at DDW 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
Global Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits Research
April 29, 2024 10:05 ET
|
Straits Research Private Limited - Reed Intelligence
New York, United States, April 29, 2024 (GLOBE NEWSWIRE) -- A drug infusion system is a medical device that allows fluids, medicines, and therapeutic substances to be administered directly into a...
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032
April 25, 2024 10:39 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...